FDA — authorised 24 December 1997
- Application: NDA020786
- Marketing authorisation holder: CHATTEM SANOFI
- Status: approved
🇺🇸 Allegra-D in United States
FDA authorised Allegra-D on 24 December 1997
Marketing authorisations
FDA — authorised 19 October 2004
- Application: NDA021704
- Marketing authorisation holder: CHATTEM SANOFI
- Status: supplemented
FDA
- Status: approved
Allegra-D in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Allegra-D approved in United States?
Yes. FDA authorised it on 24 December 1997; FDA authorised it on 19 October 2004; FDA has authorised it.
Who is the marketing authorisation holder for Allegra-D in United States?
CHATTEM SANOFI holds the US marketing authorisation.